SUMMARY: I believe the biggest challenge facing pharma companies doesn’t come from legislation or R&D. It comes from being able to recruit and hold onto people who have a passion for the industry and get discouraged by a culture of endless meetings and matrix decision making. Here are some suggestions on how, I believe, pharma can attract and keep great employees.

SUMMARY: Pharma marketing is in a funk. Somewhere over the last decade, the passionate people who believed that helping patients was the first step in excellent marketing have been replaced with people who want to know the ROI of everything. We need to hire people who have a passion for learning, exploring, and implementing great patient-centered marketing. One employee who is passionate about what they do is worth more than five who “check off the boxes” for their position.

SUMMARY:

  • Older, more experienced employees are being shoved aside in favor of more inexperienced ones.
  • The culture within pharma is driving people away, including new hires.
  • More and more meetings are based on ROI, not the voice of the patient.
  • Don’t hire people who want big salaries; hire people who want to be part of an industry that helps patients.
  • CEOs need to realign their company culture.

SUMMARY:

  • The Committee on Oversight and Reform and the Committee on Energy and Commerce is investigating the approval process for Biogen’s new Alzheimer’s drug.
  • Janet Woodcock acknowledged on Wednesday her agency may have misstepped in the handling of its polarizing approval of a new Alzheimer’s drug.
  • Biogen undertook a secret campaign, termed Project Onyx, to persuade FDA to approve Aduhelm.
  • Biogen’s reputation may be damaged beyond repair.